NCT00473369

Brief Summary

Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology. Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Setting: University and associated hospitals.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2001

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2001

Completed
6.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2007

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

May 14, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 15, 2007

Completed
Last Updated

May 15, 2007

Status Verified

May 1, 2007

First QC Date

May 14, 2007

Last Update Submit

May 14, 2007

Conditions

Keywords

atypical adenomaKi-67p53pituitaryprognosis

Eligibility Criteria

Age12 Years - 74 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • pituitary adenomas of more than 3 % of Ki67 labeling index surgically treated at Tohoku university and associated hospital

You may not qualify if:

  • pituitary adenomas of less than 3 % of Ki-67 labeling index surgically treated at Tohoku university and associated hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pituitary Diseases

Condition Hierarchy (Ancestors)

Hypothalamic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEndocrine System Diseases

Study Officials

  • Yoshikazu Ogawa, M. D.

    Department of neurosurgery, Tohoku university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 14, 2007

First Posted

May 15, 2007

Study Start

January 1, 2001

Study Completion

May 1, 2007

Last Updated

May 15, 2007

Record last verified: 2007-05